NCT05223036 2026-04-13
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Suspended
Clinical Trials
8 trialsNCT05630794 2026-04-13
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT06557733 2026-04-13
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT02961374 2022-07-26
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT04674228 2022-06-16
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
National Cancer Institute (NCI)
Completed
NCT03027401 2020-10-08
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT00033371 2020-09-29
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT00641147 2017-09-29
Curcumin in Treating Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed